Ticagrelor does not impact patient‐reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study

Ticagrelor is an antiplatelet agent for adults with coronary artery disease. The inhibition of platelet activation may decrease the frequency of vaso‐occlusion crisis (VOC) in sickle cell disease (SCD). The HESTIA2 study (NCT02482298) randomised 87 adults with SCD (aged 18–30 years) 1:1:1 to twice‐d...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Br J Haematol
Main Authors: Kanter, Julie, Abboud, Miguel R., Kaya, Banu, Nduba, Videlis, Amilon, Carl, Gottfridsson, Christer, Rensfeldt, Martin, Leonsson‐Zachrisson, Maria
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2018
Fag:
Red Cells and Iron
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587797/
https://ncbi.nlm.nih.gov/pubmed/30443999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.15646
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker